Evaluation of EverOn™ System in Medical / Surgical Ward

EarlySense Ltd.

Overview

The EverOn™ system developed by EarlySense, Ltd., the sponsor of this study, is intended to assist hospitals to better address and improve recognition and response to changes in a patient's condition. The system, monitors the patient while in bed consists of a contact-free sensor that is placed under the bed mattress and identifies respiratory and heart rates, degree of patient's movement or agitation while in bed as well as patient's actual exit out of the bed. The EverOn system does not require a physical contact with the patient, eliminating the need for any direct contact electrodes, leads, cuffs or nasal cannulae.

Study Type

OBSERVATIONAL

Conditions

Post Operative Patient Patients Requiring PCA Respiratory Patients Patients in Risk of Fall

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age above 18 years. 2. Patients not monitored continuously by telemetry, vital sign monitor or oximetry. 3. Patients not requiring special mattresses (e.g. airflow). 4. The patient or a legal guardian is ready to sign the Informed Consent. Exclusion Criteria: 1. Patients that at the judgment of the staff in the evaluating unit, are not able to communicate coherently and respond to nurses' questions. 2. Patients monitored continuously by telemetry, vital sign monitor or oximetry. 3. Patients requiring special mattresses.

Locations (1)

MetroWest Medical Center

Framingham, Massachusetts, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.